MUCOSAL EOSINOPHILS AS MARKERS OF POST- INDUCTION VEDOLIZUMAB RESPONSE IN PAEDIATRIC ULCERATIVE COLITIS

被引：0
|
作者：
Musto, F. [1 ]
Ranalli, M. [1 ]
Giordano, C. [1 ]
Bianchi, E. [1 ]
Veraldi, S. [1 ]
Oliva, S. [1 ]
D'Arcangelo, G. [1 ]
Aloi, M. [1 ]
机构：
[1] Sapienza Univ, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2023年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.14.5
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] Platelet-related indicators for predicting vedolizumab response in patients with Ulcerative Colitis
    Jiao, J.
    Liu, W.
    Wang, B.
    Cao, H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 607 - 607
  • [32] Predictive transcriptional signatures associated to vedolizumab therapy response in patients with ulcerative colitis
    Gomez, M. Camba
    Arosa, L.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto, L.
    Dominguez-Munoz, J. E.
    Barreiro-De Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 818 - 819
  • [33] Transcriptional biomarkers for vedolizumab therapy response in patients with moderate to severe Ulcerative Colitis
    Arosa Garcia, L.
    Camba-Gomez, M.
    Calvino-Suarez, C.
    Baston-Rey, I.
    Ferreiro-Iglesias, R.
    Porto, M.
    Nieto-Garcia, L.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    Conde-Aranda, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I147 - I147
  • [34] Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis
    Perry, Courtney
    Fischer, Kyle
    Elmoursi, Ahmed
    Kern, Cody
    Currier, Alden
    Kudaravalli, Praneeth
    Akanbi, Olalekan
    Tripathi, Nishant
    Yarra, Pradeep
    Su, Leon
    Flomenhoft, Deborah
    Stromberg, Arnold
    Barrett, Terrence A.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (06) : 2051 - 2058
  • [35] Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis
    Papamichael, Konstantinos
    Baert, Filip
    Tops, Sophie
    Van Assche, Gert
    Rutgeerts, Paul
    Vermeire, Severine
    Gils, Ann
    Ferrante, Marc
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (01): : 53 - 59
  • [36] Mucosal and Histologic Response to Cyclosporin in Ulcerative Colitis: A Cohort Study
    Fron, Clemence
    Belleannee, Genevieve
    Chabrun, Edouard
    Poullenot, Florian
    Subtil, Clement
    Zerbib, Frank
    Laharie, David
    Capdepont, Maylis
    GASTROENTEROLOGY, 2015, 148 (04) : S863 - S863
  • [37] Mucosal and histologic response to cyclosporin in ulcerative colitis: a cohort study
    Fron, C.
    Belleannee, G.
    Chabrun, E.
    Poullenot, F.
    Subtil, C.
    Zerbib, F.
    Capdepont, M.
    Laharie, D.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S253 - S254
  • [38] Early Treatment Response Predicts Outcome in Paediatric Ulcerative Colitis
    Gasparetto, Marco
    Wong-Spracklen, Vivien
    Torrente, Franco
    Howell, Kate
    Brennan, Maly
    Noble-Jamieson, Gabriele
    Heuschkel, Robert
    Zilbauer, Matthias
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 67 (02): : 217 - 220
  • [39] Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis
    Noman, Maja
    Ferrante, Marc
    Bisschops, Raf
    De Hertogh, Gert
    Van den Broeck, Karolien
    Rans, Karen
    Rutgeerts, Paul
    Vermeire, Severine
    Van Assche, Gert
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1085 - 1089
  • [40] Relationship between vedolizumab serum concentrations in the induction phase and early and sustained response in the first year of treatment in patients with ulcerative colitis
    German Sanchez-Hernandez, Jose
    Rebollo, Noemi
    Munoz, Fernando
    Padulles-Zamora, Nuria
    Miarons, Marta
    Martin Gutierrez, Nerea
    Martin Gil, Marcos
    Jose Otero, Maria
    FARMACIA HOSPITALARIA, 2021, 45 : 38 - 44
12345